Literature DB >> 21537863

Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer.

Hanno Matthaei1, Seung-Mo Hong, Skye C Mayo, Marco dal Molin, Kelly Olino, Raghunandan Venkat, Michael Goggins, Joseph M Herman, Barish H Edil, Christopher L Wolfgang, John L Cameron, Richard D Schulick, Anirban Maitra, Ralph H Hruban.   

Abstract

BACKGROUND: Margin status is one of the strongest prognosticators after resection of pancreatic ductal adenocarcinoma (PDAC). The clinical significance of pancreatic intraepithelial neoplasia (PanIN) at a surgical margin has not been established.
METHODS: A total of 208 patients who underwent R0 resection for PDAC between 2004 and 2008 were selected. Intraoperative frozen section slides containing the final pancreatic parenchymal transection margin were evaluated for presence or absence, number, and grade of PanINs. Data were compared to clinicopathologic factors, including patient survival.
RESULTS: PanIN lesions were present in margins in 107 of 208 patients (51.4%). Median number of PanINs per pancreatic resection margin was 1 (range, 1-11). A total of 72 patients had PanIN-1 (34.6%), 44 had PanIN-2 (21.1%), and 16 had PanIN-3 (7.2%) at their margin. Overall median survival was 17.9 (95% confidence interval, 14-21.9) months. Neither the presence nor absence of PanIN nor histological grade had any significant correlation with important clinicopathologic characteristics. There were no significant survival differences between patients with or without PanIN lesions at the resection margin or among patients with PanIN-3 (carcinoma in situ) versus lower PanIN grades. However, patients with R1 resection had a significantly worse outcome compared with patients without invasive cancer at a margin irrespective of the presence of PanIN (P=0.02).
CONCLUSIONS: The presence of PanINs at a resection margin does not affect survival in patients who undergo R0 resection for PDAC. These results have significant clinical implications for surgeons, because no additional resection seems to be indicated when intraoperative frozen sections reveal even high-grade PanIN lesions.

Entities:  

Mesh:

Year:  2011        PMID: 21537863      PMCID: PMC3166423          DOI: 10.1245/s10434-011-1745-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  20 in total

1.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

2.  A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer.

Authors:  Thomas J Howard; Joseph E Krug; Jian Yu; Nick J Zyromski; C Max Schmidt; Lewis E Jacobson; James A Madura; Eric A Wiebke; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

3.  Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins.

Authors:  J Kim; H A Reber; S M Dry; D Elashoff; S L Chen; N Umetani; M Kitago; O J Hines; K K Kazanjian; S Hiramatsu; A J Bilchik; S Yong; M Shoup; D S B Hoon
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

4.  Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Authors:  T A Sohn; C J Yeo; J L Cameron; L Koniaris; S Kaushal; R A Abrams; P K Sauter; J Coleman; R H Hruban; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

5.  Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.

Authors:  J P Neoptolemos; D D Stocken; J A Dunn; J Almond; H G Beger; P Pederzoli; C Bassi; C Dervenis; L Fernandez-Cruz; F Lacaine; J Buckels; M Deakin; F A Adab; R Sutton; C Imrie; I Ihse; T Tihanyi; A Olah; S Pedrazzoli; D Spooner; D J Kerr; H Friess; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

Review 6.  An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Authors:  Ralph H Hruban; Kyoichi Takaori; David S Klimstra; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Sandra A Biankin; Carolyn Compton; Noriyoshi Fukushima; Toru Furukawa; Michael Goggins; Yo Kato; Gunter Klöppel; Daniel S Longnecker; Jutta Lüttges; Anirban Maitra; G Johan A Offerhaus; Michio Shimizu; Suguru Yonezawa
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

7.  Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.

Authors:  C G Willett; K Lewandrowski; A L Warshaw; J Efird; C C Compton
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

8.  Relation of pancreatic duct hyperplasia to carcinoma.

Authors:  S Kozuka; R Sassa; T Taki; K Masamoto; S Nagasawa; S Saga; K Hasegawa; M Takeuchi
Journal:  Cancer       Date:  1979-04       Impact factor: 6.860

9.  Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.

Authors:  M Wagner; C Redaelli; M Lietz; C A Seiler; H Friess; M W Büchler
Journal:  Br J Surg       Date:  2004-05       Impact factor: 6.939

10.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Authors:  John P Neoptolemos; Deborah D Stocken; Helmut Friess; Claudio Bassi; Janet A Dunn; Helen Hickey; Hans Beger; Laureano Fernandez-Cruz; Christos Dervenis; François Lacaine; Massimo Falconi; Paolo Pederzoli; Akos Pap; David Spooner; David J Kerr; Markus W Büchler
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

View more
  20 in total

1.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

Review 2.  [Frozen section diagnostics in visceral surgery. Liver, bile ducts and pancreas].

Authors:  C Mogler; C Flechtenmacher; P Schirmacher; F Bergmann
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

3.  Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer.

Authors:  Benjamin G Hassid; Aimee L Lucas; Marcela Salomao; Chunhua Weng; Feng Liu; Lauren G Khanna; Sheila Kumar; Caroline Hwang; John A Chabot; Harold Frucht
Journal:  Pancreas       Date:  2014-10       Impact factor: 3.327

4.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

Review 5.  Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.

Authors:  Colin M Court; Jacob S Ankeny; Shuang Hou; Hsian-Rong Tseng; James S Tomlinson
Journal:  Expert Rev Mol Diagn       Date:  2015-09-21       Impact factor: 5.225

6.  Vascular invasion in infiltrating ductal adenocarcinoma of the pancreas can mimic pancreatic intraepithelial neoplasia: a histopathologic study of 209 cases.

Authors:  Seung-Mo Hong; Michael Goggins; Christopher L Wolfgang; Richard D Schulick; Barish H Edil; John L Cameron; Adriana Handra-Luca; Joseph M Herman; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2012-02       Impact factor: 6.394

Review 7.  Adenocarcinoma of the pancreas.

Authors:  Ralph H Hruban; David S Klimstra
Journal:  Semin Diagn Pathol       Date:  2014-09-02       Impact factor: 3.464

8.  Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications.

Authors:  Hanno Matthaei; Philipp Lingohr; Anke Strässer; Dimo Dietrich; Babak Rostamzadeh; Simone Glees; Martin Roering; Pauline Möhring; Martin Scheerbaum; Burkhard Stoffels; Jörg C Kalff; Nico Schäfer; Glen Kristiansen
Journal:  Virchows Arch       Date:  2014-11-26       Impact factor: 4.064

Review 9.  Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia.

Authors:  Yasunori Sato; Motoko Sasaki; Kenichi Harada; Shinichi Aishima; Toshio Fukusato; Hidenori Ojima; Yae Kanai; Masayoshi Kage; Yasuni Nakanuma; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2013-04-25       Impact factor: 7.527

10.  Histological characteristics of biliary intraepithelial neoplasia-3 and intraepithelial spread of cholangiocarcinoma.

Authors:  Yasunori Sato; Kenichi Harada; Motoko Sasaki; Yasuni Nakanuma
Journal:  Virchows Arch       Date:  2013-02-28       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.